Regulation of ovarian UT-OC-2 carcinoma cells by cytokines: Effects on cell proliferation, activation of transcription factors and apoptosis

References

• Stern RC, Dash R, Bentley RC, Snyder MJ, Haney AF, Robboy SJ. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol. 2001; 20: 133–9
   PubMed Web of Science ®Google Scholar
• Berhuck A, Kohler MF, Boente MP, Rodriguez GC, Whitaker RS, Bast RC. Growth regulation and transformation of ovarian epithelium. Cancer. 1993; 71: 545–51
   PubMed Web of Science ®Google Scholar
• Coukos G, Conejo-Garcia JR, Buckanovich R, Benencia F. Vascular leukocytes: a population with angiogenic and immunosuppressive properties highly presented in ovarian cancer. Adv Exp Med Biol. 2007; 590: 183–93
   Web of Science ®Google Scholar
• Saas P, Bonnefoy F, Kury-Paulin S, Kleinclauss F, Perruche S. Mediators involved in the immunomodulatory effects of apoptotic cells. Transplantation. 2007; 84: S31–4
   PubMed Web of Science ®Google Scholar
• Marth C, Zeimet AG, Herold M, Brumm C, Windbichler G, Muller-Holzner E, et al. Different effects of interferons, interleukin-1β and tumor necrosis factor-α in normal and malignant human ovarian epithelial cells. Int J Cancer. 1996; 67: 826–30
   PubMed Web of Science ®Google Scholar
• Powell CB, Scott JH, Collins JL. Characerization of the protein synthesis independent TNF-α lytic mechanism in human ovarian and cervical carcinoma cell lines. Gynecol Oncol. 1996; 62: 42–8
   PubMed Web of Science ®Google Scholar
• Seppänen M, Vihko KK. Activation of transcription factor NF-KB by growth inhibitory cytokines in vulvar carcinoma cells. Immunol Lett. 2000; 74: 103–9
   PubMed Web of Science ®Google Scholar
• Massagué J. The transforming growth factor family. Ann Rev Cell Biol. 1990; 6: 597–641
   PubMedGoogle Scholar
• Salmon SE, Liu R. Effects of granulocyte-macrophage colony-stimulating factor on in vitro growth of human solid tumors. J Clin Oncol. 1989; 7: 1346–50
   PubMed Web of Science ®Google Scholar
• Pujade-Lauraine E, Guastalla JP, Colombo N, Devillier P, Francois E, Fumoleau P, et al. Intraperitoneal recombinant interferon-gamma in ovarian cancer patients with residual disease at second-look laparotomy. J Clin Oncol. 1996; 14: 343–50
   PubMed Web of Science ®Google Scholar
• Pestka S. The inferferons: 50 years after their discovery, there is much more to learn. J Biol Chem. 2007; 282: 20047–51
   PubMed Web of Science ®Google Scholar
• Brach MA, Gruss H-J, Sott C, Herrmann F. The mitogenic response to tumor necrosis factor alpha requires c-Jun/AP-1. Mol Cell Biol. 1993; 13: 4284–90
   PubMed Web of Science ®Google Scholar
• Seppänen M, Vihko KK, Henttinen T, Lin L, Punnonen J, Grénman S, et al. Regulation of UM-EC-3 endometrial carcinoma cells by cytokines: inhibitory effects on cell proliferation associated with activation of transcription factor AP-1. Oncol Res. 1998; 10: 575–8
   PubMed Web of Science ®Google Scholar
• Bours V, Dejardin E, Goujon-Letawe F, Merville M, Castronovo V. The NF-κB transcription factor and cancer: high expression of NF-κB and IκB-related proteins in tumor cell lines. Biochem Pharmacol. 1994; 47: 145–9
   PubMed Web of Science ®Google Scholar
• Engblom P, Rantanen V, Kulmala J, Grénman S. Paclitaxel and cispaltin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay. Anticaner Res. 1996; 16: 1743–8
   PubMed Web of Science ®Google Scholar
• Asantila T, Toivanen P. Potentiation by fluorodeoxyuridine of 125I-deoxyuridine uptake by human and chicken lymphocytes in the quantitation of mitogenic response. J Immunol Methods. 1974; 6: 73–82
   PubMed Web of Science ®Google Scholar
• Smith C, Williams G. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature. 1989; 337: 181–4
   PubMed Web of Science ®Google Scholar
• Andrews N, Faller D. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991; 19: 249
   PubMed Web of Science ®Google Scholar
• Seppänen M, Lin L, Punnonen J, Grenman S, Punnonen R, Vihko KK. Regulation of UT-OC-3 ovarian carcinoma cells by cytokines: inhibitory effects on cell proliferation and activation of transcription factors AP-1 and NF-κB. Eur J Endocrinol. 2000; 142: 393–401
   PubMed Web of Science ®Google Scholar
• Mathieu C, Jozan S, Mazars P, Cimme MG, Moisand A, Valette A. Density-dependent induction of apoptosis by transforming growth factor-b1 in a human ovarian carcinoma cell line. Exp Cell Res. 1995; 216: 13–20
   PubMed Web of Science ®Google Scholar
• Sovak M, Bellas R, Kim D, Zanieski G, Rogers A, Traish A, et al. Aberrant nuclear factor-kB/Rel expression and the pathogenesis of breast cancer. J Clin Invest. 1991; 100: 2952–60
   Google Scholar
• DeJaco P, Asselain B, Orlandi C, Fridman WH, Teillaud J-L. Evaluation of circulating tumor necrosis factor-α in patients with gynecological malignancies. Int J Cancer. 1991; 4: 375–8
   Google Scholar
• Dixit V, Marks R, Sarma V, Prochowniks E. The antimitogenic action of tumor necrosis factor is associated with increased AP-1/c-jun proto-oncogene transcription. J Biol Chem. 1989; 264: 16905–9
   PubMed Web of Science ®Google Scholar
• Spinner DM, Brandstetter T, Kiechle-Schwarz M, Du Bois A, Angel P, Bauknecht T. C-jun expression and growth stimulation in human ovarian carcinoma cell lines following exposure to cytokines. Int J Cancer. 1995; 62: 423–7
   Google Scholar
• Kim S-J, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, et al. Autoinduction of transforming growth factor (1 is mediated by the AP-1 complex. Mol Cell Biol. 1990; 10: 1492–7
   PubMed Web of Science ®Google Scholar